USPTO serial 79435097
Reviewed by CopyMark Law Group
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Matthew D. Asbell
Matthew D. Asbell Lippes Mathias, LLP420 Lexington Avenue, Suite 2005New York, NY 10170United States| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Urinalysis test strips for medical purposes; reagents for the diagnosis of pregnancy for medical purposes; reagents for the diagnosis of hepatitis B for medical purposes; diagnostic test reagents for medical or veterinary purposes; reagents and media for medical and veterinary diagnostic purposes; medical diagnostic reagents; diagnostic chemical reagents for medical use; clinical diagnostic reagents for medical purposes; diagnostic biomarker reagents for medical purposes; medical diagnostic test strips for blood and urine analysis; in vitro diagnostic preparations for medical purposes; preparations for detecting mutation in prion genes for medical purposes; diagnostic preparations for medical purposes for detecting mutation in prion genes; medical diagnostic reagents for immunization disease; chemical preparations for testing blood for medical purposes; chemically treated papers for use in the detection of fecal occult blood; reagents for use in medical genetic testing; pharmaceutical preparations for diagnosing tuberculosis | ACTIVE | — |
| 010 | Medical apparatus for automatic diagnosis of tuberculosis; urine testing instruments for medical diagnostic purposes; continuous blood glucose monitor for medical purposes; medical immunoassay apparatus; cell testing apparatus for medical purposes; real-time gene amplification equipment for medical use; haemocytometers being a cell counter for medical purposes; devices for measuring blood sugar; blood testing apparatus; blood analysis equipment | ACTIVE | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 26, 2026 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| May 26, 2026 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| May 26, 2026 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| May 26, 2026 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| May 26, 2026 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Apr 7, 2026 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Apr 7, 2026 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Apr 1, 2026 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Mar 12, 2026 | RFNT | REFUSAL PROCESSED BY IB | — |
| Mar 11, 2026 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Mar 10, 2026 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 10, 2026 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 10, 2026 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 26, 2026 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Feb 26, 2026 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jan 30, 2026 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jan 29, 2026 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 15, 2026 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 23, 2025 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Oct 23, 2025 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Oct 20, 2025 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |